- Home
- OSCR vs TECH Comparison
OSCR vs TECH Comparison
Compare OSCR & TECH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | OSCR | TECH |
|---|---|---|
| Founded | 2012 | 1976 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Accident &Health Insurance | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.0B | 11.4B |
| IPO Year | 2021 | 1995 |
Fundamental Metrics
Financial Performance| Metric | OSCR | TECH |
|---|---|---|
| Price | $29.80 | $72.42 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 11 | 13 |
| Target Price | $35.40 | ★ $70.50 |
| AVG Volume (30 Days) | ★ 4.6M | 2.6M |
| Earning Date | 11-05-2026 | 11-04-2026 |
| Dividend Yield | N/A | ★ 0.44% |
| EPS Growth | N/A | ★ 152.17 |
| EPS | ★ 3.16 | 1.16 |
| Revenue | ★ $11,701,427,000.00 | $1,215,039,000.00 |
| Revenue This Year | $60.08 | $4.34 |
| Revenue Next Year | $11.01 | $9.79 |
| P/E Ratio | ★ $9.48 | $62.40 |
| Revenue Growth | ★ 27.50 | N/A |
| 52 Week Low | $10.69 | $43.20 |
| 52 Week High | $34.48 | $72.69 |
Technical Indicators
Market Signals| Indicator | OSCR | TECH |
|---|---|---|
| Relative Strength Index (RSI) | 49.59 | 56.02 |
| Support Level | $28.16 | $72.11 |
| Resistance Level | $32.73 | $72.66 |
| Average True Range (ATR) | 1.60 | 0.16 |
| MACD | -0.19 | -0.05 |
| Stochastic Oscillator | 41.10 | 48.08 |
Price Performance
Historical ComparisonAbout OSCR Oscar Health Inc.
Oscar Health Inc is a healthcare technology company built around a full stack technology platform and a relentless focus on serving its members. It offers Individual & Family plans and health technology solutions that power the healthcare industry. Oscar operates as one segment to sell insurance to individuals, families and employees through the federal and state-run healthcare exchanges formed in conjunction with the Patient Protection and Affordable Care Act (ACA) and leverages its technology platform to provide services via its Oscar offering.
About TECH Bio-Techne Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.